Oncocross Expands Collaboration with JW Pharmaceutical on Developing Innovative New Drugs Using AI in Anticancer and Regenerative Medicine

Contributed by: Business Wire

Logo

Tags

Research

Technology

Health Technology

Other Health

Biotechnology

Pharmaceutical

Health

Science

Oncology

Artificial Intelligence

Research, AI, Oncology, Drug development

More Like This

PR Newswire associated0

J INTS BIO Launches AI-Supercomputing Alliance to Transform Cancer Therapy

PR Newswire associated0

XtalPi to Present the Latest Progress of Its AI Cancer Vaccine Design Platform at AACR 2024

Crown Bioscience Announces New Preclinical and Translational Oncology Data Across Ten Poster Presentations at AACR 2024

PR Newswire associated0

J INTS BIO Presents Research Results for Next-Generation Innovative Anticancer Therapeutics 'JIN-A02' and 'JIN-001' at AACR 2025

How Cutting-Edge Immunotherapies Are Redefining Cancer Treatment Options

Owkin Unveils AI-Driven Oncology and Immunology Pipeline, In-Licenses Best-in-Class Asset OKN4395

PR Newswire associated0

Pierre Fabre Laboratories and Iktos Announce an Integrated AI-Driven Drug Discovery Collaboration in Oncology

Crown Bioscience and NEXT Oncology Cement Partnership Extension